Cell-specific cargo delivery using synthetic bacterial spores

Minsuk Kong; Domenico D’Atri; Maria Teresa Bilotta; Bailey Johnson; Taylor B. Updegrove; Devorah L. Gallardo; Federico Machinandiarena; I-Lin Wu; Maira Alves Constantino; Stephen M. Hewitt; Kandice Tanner; David J. Fitzgerald; Kumaran S. Ramamurthi

Cell Reports (Jan 2023)

Cell-specific cargo delivery using synthetic bacterial spores

Minsuk Kong,
Domenico D’Atri,
Maria Teresa Bilotta,
Bailey Johnson,
Taylor B. Updegrove,
Devorah L. Gallardo,
Federico Machinandiarena,
I-Lin Wu,
Maira Alves Constantino,
Stephen M. Hewitt,
Kandice Tanner,
David J. Fitzgerald,
Kumaran S. Ramamurthi

Affiliations

Minsuk Kong: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Department of Food Science and Technology, Seoul National University of Science and Technology, Seoul 01811, South Korea
Domenico D’Atri: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Maria Teresa Bilotta: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Bailey Johnson: Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Taylor B. Updegrove: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Devorah L. Gallardo: Laboratory Animal Sciences Program, Leidos Biomedical Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Federico Machinandiarena: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
I-Lin Wu: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Maira Alves Constantino: Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Stephen M. Hewitt: Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Kandice Tanner: Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Corresponding author
David J. Fitzgerald: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Corresponding author
Kumaran S. Ramamurthi: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Corresponding author

Journal volume & issue: Vol. 42, no. 1
p. 111955

Abstract

Read online

Summary: Delivery of cancer therapeutics to non-specific sites decreases treatment efficacy while increasing toxicity. In ovarian cancer, overexpression of the cell surface marker HER2, which several therapeutics target, relates to poor prognosis. We recently reported the assembly of biocompatible bacterial spore-like particles, termed “SSHELs.” Here, we modify SSHELs with an affibody directed against HER2 and load them with the chemotherapeutic agent doxorubicin. Drug-loaded SSHELs reduce tumor growth and increase survival with lower toxicity in a mouse tumor xenograft model compared with free drug and with liposomal doxorubicin by preferentially accumulating in the tumor mass. Target cells actively internalize and then traffic bound SSHELs to acidic compartments, whereupon the cargo is released to the cytosol in a pH-dependent manner. We propose that SSHELs represent a versatile strategy for targeted drug delivery, especially in cancer settings.

CP: Cancer

Published in Cell Reports

ISSN: 2211-1247 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Science: Biology (General)
Website: http://www.cell.com/cell-reports/home

About the journal

Abstract

Keywords